Immune related adverse trang 1 tải miễn phí từ TAILIEUCHUNG

"Immune related adverse" trang 1 - tải miễn phí từ Tailieuchung

Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy

Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy

7 58 1

Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer

Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer

14 40 1

Challenges in diagnosis and management of neutropenia upon exposure to immunecheckpoint inhibitors: Meta-analysis of a rare immune-related adverse side effect

Challenges in diagnosis and management of neutropenia upon exposure to immunecheckpoint inhibitors: Meta-analysis of a rare immune-related adverse side effect

15 65 0

Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: Potential role of Th1-dominant immune response in immune-related adverse events: Two case reports

Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: Potential role of Th1-dominant immune response in immune-related adverse events: Two case reports

7 44 0

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab

10 54 0

Correlation between immune-related adverse events and therapeutic efects of nivolumab in patients with malignant pleural mesothelioma

Correlation between immune-related adverse events and therapeutic efects of nivolumab in patients with malignant pleural mesothelioma

6 21 1

CA19-9 in combination with P-CRP as a predictive marker of immune-related adverse events in patients with recurrent or unresectable advanced gastric cancer treated with nivolumab

CA19-9 in combination with P-CRP as a predictive marker of immune-related adverse events in patients with recurrent or unresectable advanced gastric cancer treated with nivolumab

10 10 1

Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibody

Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibody

8 38 1

Questionnaire-based detection of immunerelated adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors

Questionnaire-based detection of immunerelated adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors

10 32 1

The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/ PD-L1 plus anti-CTLA-4): A systematic review and meta-analysis

The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/ PD-L1 plus anti-CTLA-4): A systematic review and meta-analysis

10 42 0

Immunotherapy and associated immunerelated adverse events at a large UK centre: A mixed methods study

Immunotherapy and associated immunerelated adverse events at a large UK centre: A mixed methods study

11 68 1

Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinoma

Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinoma

5 64 0

Re-challenging immune checkpoint inhibitor in a patient with advanced nonsmall cell lung cancer: A case report

Re-challenging immune checkpoint inhibitor in a patient with advanced nonsmall cell lung cancer: A case report

4 38 1

Case report: Reinitiating pembrolizumab treatment after small bowel perforation

Case report: Reinitiating pembrolizumab treatment after small bowel perforation

9 58 0

Acral vascular necrosis associated with immune-check point inhibitors: Case report with literature review

Acral vascular necrosis associated with immune-check point inhibitors: Case report with literature review

6 44 0

IgG4-related pleural disease in a patient with pulmonary adenocarcinoma under durvalumab treatment: A case report

IgG4-related pleural disease in a patient with pulmonary adenocarcinoma under durvalumab treatment: A case report

5 51 1

Association of advanced age and cancer history with autoimmune disease in melanoma patients: A cross-sectional study

Association of advanced age and cancer history with autoimmune disease in melanoma patients: A cross-sectional study

8 44 3

Immune checkpoint inhibitors-related myocarditis in patients with cancer: An analysis of international spontaneous reporting systems

Immune checkpoint inhibitors-related myocarditis in patients with cancer: An analysis of international spontaneous reporting systems

9 28 1

Clinical features as potential prognostic factors in patients treated with nivolumab for highly pretreated metastatic gastric cancer: A multicenter retrospective study

Clinical features as potential prognostic factors in patients treated with nivolumab for highly pretreated metastatic gastric cancer: A multicenter retrospective study

12 23 3

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.